These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 10980839)
1. Recent trials of antithrombotics in the management of patients with acute coronary syndromes. Harrington RA Curr Cardiol Rep; 1999 Sep; 1(3):181-3. PubMed ID: 10980839 [No Abstract] [Full Text] [Related]
2. GUSTO IV: expanding therapeutic options in acute coronary syndromes. Lincoff AM Am Heart J; 2000 Dec; 140(6 Suppl):S103-14. PubMed ID: 11100004 [No Abstract] [Full Text] [Related]
3. Use of low-molecular-weight heparin and glycoprotein IIb/IIIa inhibitors in acute coronary syndromes. Fernandez JS; Sadaniantz A Med Health R I; 2001 Feb; 84(2):37-43. PubMed ID: 11272658 [No Abstract] [Full Text] [Related]
4. Management of acute coronary syndromes. Schulman SP; Fessler HE Am J Respir Crit Care Med; 2001 Sep; 164(6):917-22. PubMed ID: 11587971 [No Abstract] [Full Text] [Related]
5. Low-molecular-weight heparins for the treatment of acute coronary syndromes. Wong GC; Giugliano RP Semin Vasc Med; 2003 Nov; 3(4):391-402. PubMed ID: 15199446 [TBL] [Abstract][Full Text] [Related]
14. Tirofiban in unstable coronary disease. Liron M N Engl J Med; 1998 Oct; 339(16):1163-5. PubMed ID: 9776651 [No Abstract] [Full Text] [Related]
15. Use of glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing coronary revascularization. Popma JJ Haemostasis; 1999 Dec; 29 Suppl S1():69-71. PubMed ID: 10629407 [TBL] [Abstract][Full Text] [Related]
16. Platelet glycoprotein IIb/IIIa inhibitor therapy in non-ST segment elevation acute coronary syndromes. Elmouchi DA; Bates ER Minerva Cardioangiol; 2003 Oct; 51(5):547-60. PubMed ID: 14551523 [TBL] [Abstract][Full Text] [Related]
17. Platelet glycoprotein IIB/IIIA receptor antagonists. An asset for treatment of unstable coronary syndromes and coronary intervention. Ronner E; Dykun Y; van den Brand MJ; van der Wieken LR; Simoons ML Eur Heart J; 1998 Nov; 19(11):1608-16. PubMed ID: 9857912 [No Abstract] [Full Text] [Related]
18. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators N Engl J Med; 1998 May; 338(21):1488-97. PubMed ID: 9599103 [TBL] [Abstract][Full Text] [Related]
19. Initial experience with the low-molecular-weight heparin, enoxaparin, in combination with the platelet glycoprotein IIb/IIIa blocker, tirofiban, in patients with non-ST segment elevation acute coronary syndromes. Cohen M J Invasive Cardiol; 2000 Dec; 12 Suppl E():E5-9;discussion E25-8. PubMed ID: 11156722 [TBL] [Abstract][Full Text] [Related]
20. GP IIb/IIIa inhibitors in coronary artery disease management: what the latest trials tell us. Chew DP; Moliterno DJ Cleve Clin J Med; 2001 Dec; 68(12):1017-23. PubMed ID: 11765119 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]